Example: bachelor of science
Medication-Related Osteonecrosis of the Jaw—2014 Update
there is a reduction in the risk of vertebral, non-vertebral, and hip fractures in osteoporotic patients.20,21 Denosumab (Xgeva®) is also effective in reducing SRE related to met-astatic bone disease from solid tumors when administered monthly.22,23 Denosumab therapy is not indicated for the treatment of multiple myeloma. Interestingly, in ...
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: